No phaseNot yet recruitingAge-related condition
Assessing the Potential for Improved Joint Health and Wellbeing by Providing a Whole Salmon Oil With Undenatured Type II Collagen Compared to Type II Collagen Alone
A Decentralized, Active-Controlled Clinical Trial Investigating the Combination of NT-II® Salmon Bone Undenatured Type II Collagen and OmeGo® Salmon Oil Versus UC-II® Undenatured Chicken Type II Collagen on Knee Pain, Function, and Inflammatory Biomarkers in Adults Who Regularly Suffer From Mild to Moderate Knee Discomfort
- Sponsor
- Hofseth Biocare ASA (Industry)
- Enrollment
- 150 planned
- Conditions
- Joint Discomfort; Wellbeing; Quality of Life
- Interventions
- Undenatured collagen; Whole salmon oil
- Ages
- adults, older adults
- Registry
- NCT07875101
Full record on ClinicalTrials.gov
From the registry
This study evaluates the combination of NT-II® salmon undenatured type II collagen with OmeGo® salmon oil in adults who regularly experience knee discomfort. The aim is to assess whether participants experience faster and greater improvements in joint health with the combination than undenatured type II collagen alone .
Primary outcomes
- Change in knee pain measured by visual analogue scale (VAS) score
- Change in KOOS (Knee Injury and Osteoarthritis Outcome Score) Quality of Life (QoL) score
History
Study completion expected
Primary completion expected
Started
Registered